SUNNYVALE, Calif.--Hyseq announced the appointment of Dennis Ballinger as senior director of functional genomics/cardiovascular. The company said it plans to strengthen its development program in the genetic causes of cardiovascular diseases. Ballinger joined Hyseq from Myriad Genetics, where he was director of coronary heart disease research.
Hyseq said it is leveraging its high-throughput proprietary sequencing technology to identify valuable gene-based therapeutic candidates. The company claimed it has processed more than 7.5 million sequences and filed patents on over 95,000 novel gene discoveries.